Non-specific adsorption of complement proteins affects complement activation pathways of gold nanomaterials

Abstract The complement system is a key humoral component of innate immunity, serving as the first line of defense against intruders, including foreign synthetic nanomaterials. Although gold nanomaterials (AuNMs) are widely used in nanomedicine, their immunological response is not well understood. Using AuNMs of three shapes commonly used in biomedical applications: spherical gold nanoparticles, gold nanostars and gold nanorods, we demonstrated that AuNMs activated whole complement system, leading to the formation of SC5b-9 complex. All three complement pathways were simultaneously activated by all the AuNMs. Recognition molecules of the complement system interacted with all AuNMs in vitro, except for l-ficolin, but the correlation between these interactions and corresponding complement pathway activation was only observed in the classical and alternative pathways. We also observed the mediating role of complement activation in cellular uptake of all AuNMs by human U937 promonocytic cells, which expresses complement receptors. Taken together, our results highlighted the potential immunological challenges for clinical applications of AuNMs that were often overlooked.

[1]  G. Frens Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions , 1973 .

[2]  E. Brown,et al.  Complement activation. , 1981, Immunology today.

[3]  P. Kremsner,et al.  Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. , 1998, The Journal of infectious diseases.

[4]  Jinhua Lu,et al.  Human l‐ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen‐like (FBG) domain , 1998, FEBS letters.

[5]  T. Fujita,et al.  Cutting Edge: Complement-Activating Complex of Ficolin and Mannose-Binding Lectin-Associated Serine Protease1 , 2000, The Journal of Immunology.

[6]  V. Ferriani,et al.  Ontogeny of Complement Regulatory Proteins – Concentrations of Factor H, Factor I, C4b‐Binding Protein, Properdin and Vitronectin in Healthy Children of Different Ages and in Adults , 2003, Scandinavian journal of immunology.

[7]  F M Muggia,et al.  Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  小林 邦彦 Mannose binding lectin (MBL) : 最近の知見 , 2003 .

[9]  Kazunori Kataoka,et al.  PEGylated nanoparticles for biological and pharmaceutical applications. , 2003, Advanced drug delivery reviews.

[10]  Stephen Tomlinson,et al.  Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. , 2003, The Journal of clinical investigation.

[11]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[12]  T. Hartung,et al.  L-Ficolin Specifically Binds to Lipoteichoic Acid, a Cell Wall Constituent of Gram-Positive Bacteria, and Activates the Lectin Pathway of Complement 1 , 2004, The Journal of Immunology.

[13]  T. Fujita,et al.  Human Mannose-binding Lectin and l-Ficolin Function as Specific Pattern Recognition Proteins in the Lectin Activation Pathway of Complement* , 2004, Journal of Biological Chemistry.

[14]  R. Nisihara,et al.  Significantly increased levels of mannose‐binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency , 2004, Clinical and experimental immunology.

[15]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[16]  Janos Szebeni,et al.  Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. , 2005, Toxicology.

[17]  C. Cudrici,et al.  The role of the complement system in innate immunity , 2005, Immunologic research.

[18]  Malcolm L. H. Green,et al.  Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.

[19]  Younan Xia,et al.  Gold nanostructures: engineering their plasmonic properties for biomedical applications. , 2006, Chemical Society reviews.

[20]  T. Fujita,et al.  Lectin complement system and pattern recognition. , 2006, Immunobiology.

[21]  T. Kuijpers,et al.  High prevalence of mannose‐binding lectin (MBL) deficiency in premature neonates , 2006, Clinical and experimental immunology.

[22]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[23]  T. Ross,et al.  Complement-mediated activation of the adaptive immune responses , 2006, Immunologic research.

[24]  P. Jain,et al.  Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. , 2007, Nanomedicine.

[25]  B. Hansen,et al.  Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. , 2007, Molecular immunology.

[26]  M. Boermeester,et al.  Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Malcolm L. H. Green,et al.  Effects of covalent functionalization on the biocompatibility characteristics of multi-walled carbon nanotubes. , 2008, Journal of nanoscience and nanotechnology.

[28]  Naomi J Halas,et al.  Nanoshell-enabled photothermal cancer therapy: impending clinical impact. , 2008, Accounts of chemical research.

[29]  E. Esenturk,et al.  Surface-enhanced Raman scattering spectroscopy via gold nanostars , 2009 .

[30]  Malini Olivo,et al.  Control of optical contrast using gold nanoshells for optical coherence tomography imaging of mouse xenograft tumor model in vivo. , 2009, Journal of biomedical optics.

[31]  S. Hsu,et al.  Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. , 2009, Small.

[32]  R. H. Scofield,et al.  Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum. , 2009, Biotechnology journal.

[33]  Darren J. Martin,et al.  Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.

[34]  M. Matsushita,et al.  L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. , 2009, Molecular immunology.

[35]  J. Jensenius,et al.  Mannose-Binding Lectin (MBL) Substitution: Recovery of Opsonic Function In Vivo Lags behind MBL Serum Levels1 , 2009, The Journal of Immunology.

[36]  Q. Hu,et al.  Specifically Binding of L-ficolin to N-glycans of HCV Envelope Glycoproteins E1 and E2 Leads to Complement Activation , 2009, Cellular and Molecular Immunology.

[37]  S. Libutti,et al.  Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Parag Aggarwal,et al.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[39]  Lawrence Tamarkin,et al.  Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine , 2010, Clinical Cancer Research.

[40]  John D Lambris,et al.  Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.

[41]  Wen-chao Song,et al.  Complement and its role in innate and adaptive immune responses , 2010, Cell Research.

[42]  D. Hourcade,et al.  Properdin: emerging roles of a pattern-recognition molecule. , 2010, Annual review of immunology.

[43]  Hendrik Engelbrecht,et al.  Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[44]  C. Sharma,et al.  Blood protein adsorption and compatibility studies of gold nanoparticles , 2011 .

[45]  Istvan Toth,et al.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.

[46]  Davoud Ahmadvand,et al.  Material properties in complement activation. , 2011, Advanced drug delivery reviews.

[47]  A. Popovtzer,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study , 2011, International journal of nanomedicine.

[48]  J. Lausmaa,et al.  Immune complement activation is attenuated by surface nanotopography , 2011, International journal of nanomedicine.

[49]  Willi Paul,et al.  Green synthesis of gold nanoparticles with Zingiber officinale extract: Characterization and blood compatibility , 2011 .

[50]  M. Tóth,et al.  In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. , 2011, Biomaterials.

[51]  Rodney F. Minchin,et al.  Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. , 2012, ACS nano.

[52]  D. Fraser,et al.  Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules. , 2012, Biomacromolecules.

[53]  Gwo-Bin Lee,et al.  Size-Dependent Attenuation of TLR9 Signaling by Gold Nanoparticles in Macrophages , 2012, The Journal of Immunology.

[54]  Yechezkel Barenholz,et al.  Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[55]  James Chen Yong Kah,et al.  Exploiting the protein corona around gold nanorods for loading and triggered release. , 2012, ACS nano.

[56]  Glenn P. Goodrich,et al.  Evaluation of the Toxicity of Intravenous Delivery of Auroshell Particles (Gold–Silica Nanoshells) , 2012, International journal of toxicology.

[57]  Ming-hui Zhao,et al.  Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis , 2013, BMC Nephrology.

[58]  Chun Xing Li,et al.  Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres , 2014, Particle and Fibre Toxicology.

[59]  J. Kah Stability and aggregation assays of nanoparticles in biological media. , 2013, Methods in molecular biology.

[60]  D. Cliffel,et al.  In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[61]  Mingwu Shen,et al.  Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. , 2013, Biomaterials.

[62]  Zhe Wang,et al.  Single Continuous Wave Laser Induced Photodynamic/Plasmonic Photothermal Therapy Using Photosensitizer‐Functionalized Gold Nanostars , 2013, Advanced materials.

[63]  Thomas J. Anchordoquy,et al.  Questioning the use of PEGylation for drug delivery , 2013, Drug Delivery and Translational Research.

[64]  Hongjie Dai,et al.  Single-walled carbon nanotube surface control of complement recognition and activation. , 2013, ACS nano.

[65]  T. Andresen,et al.  Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[66]  Rodney F. Minchin,et al.  Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses , 2012, Nanotoxicology.

[67]  Fabrizio Mancin,et al.  Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles. , 2013, Nanoscale.

[68]  T. Mészáros,et al.  Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[69]  Anil K Patri,et al.  Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[70]  T. Anchordoquy,et al.  Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. , 2014, Drug discovery today.

[71]  Robert B Sim,et al.  Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[72]  John D Lambris,et al.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles. , 2014, Biomaterials.

[73]  Seyed Moein Moghimi,et al.  Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum , 2014, Particle and Fibre Toxicology.

[74]  E. Conway,et al.  Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry. , 2014, ACS nano.

[75]  P. Pelicon,et al.  Size-Dependent Effects of Gold Nanoparticles Uptake on Maturation and Antitumor Functions of Human Dendritic Cells In Vitro , 2014, PloS one.

[76]  M. Ng,et al.  Understanding aggregation-based assays: nature of protein corona and number of epitopes on antigen matters , 2015 .

[77]  V. Frémeaux-Bacchi,et al.  Complement System Part I – Molecular Mechanisms of Activation and Regulation , 2015, Front. Immunol..

[78]  T. Fujita,et al.  New insights into the role of ficolins in the lectin pathway of innate immunity. , 2015, International review of cell and molecular biology.

[79]  S. Lai,et al.  Anti-PEG immunity: emergence, characteristics, and unaddressed questions. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[80]  Tracy Vargo-Gogola,et al.  Gold nanoparticles as contrast agents in x-ray imaging and computed tomography. , 2015, Nanomedicine.

[81]  V. M. Holers,et al.  Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. , 2015, ACS nano.

[82]  H. Khan,et al.  Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[83]  J. Kah,et al.  Optimizing gold nanostars as a colloid-based surface-enhanced Raman scattering (SERS) substrate , 2015 .

[84]  J. Pfau,et al.  Selective inhibitory effects of 50-nm gold nanoparticles on mouse macrophage and spleen cells , 2016, Journal of immunotoxicology.

[85]  Robert B Sim,et al.  Complement Deposition on Nanoparticles Can Modulate Immune Responses by Macrophage, B and T Cells. , 2016, Journal of Biomedical Nanotechnology.

[86]  Sung Tae Kim,et al.  Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona. , 2016, ACS nano.

[87]  C. Murphy,et al.  One low-dose exposure of gold nanoparticles induces long-term changes in human cells , 2016, Proceedings of the National Academy of Sciences.

[88]  D. Kingston,et al.  Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery. , 2016, Bioconjugate chemistry.

[89]  R. Shukla,et al.  Photothermal therapy mediated by gum Arabic-conjugated gold nanoparticles suppresses liver preneoplastic lesions in mice. , 2016, Journal of photochemistry and photobiology. B, Biology.

[90]  K. Soo,et al.  Exploiting the protein corona around gold nanorods for low-dose combined photothermal and photodynamic therapy. , 2017, Journal of materials chemistry. B.